USD 16.41
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | 26.45 Billion JPY | -2.14% |
2023 | 27.03 Billion JPY | 2.18% |
2022 | 26.45 Billion JPY | -5.52% |
2021 | 27.99 Billion JPY | 22.79% |
2020 | 22.8 Billion JPY | 30.87% |
2019 | 17.42 Billion JPY | 1.5% |
2018 | 17.16 Billion JPY | 18.79% |
2017 | 14.45 Billion JPY | 51.67% |
2016 | 9.52 Billion JPY | 27.81% |
2015 | 7.45 Billion JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 FY | 26.45 Billion JPY | -2.14% |
2024 Q1 | 5.12 Billion JPY | -13.03% |
2024 Q4 | 6.06 Billion JPY | 46.28% |
2024 Q3 | 4.14 Billion JPY | -62.65% |
2024 Q2 | 11.1 Billion JPY | 116.68% |
2023 Q2 | 10.76 Billion JPY | 70.31% |
2023 Q1 | 6.32 Billion JPY | 1.23% |
2023 FY | 27.03 Billion JPY | 2.18% |
2023 Q4 | 5.89 Billion JPY | 45.6% |
2023 Q3 | 4.04 Billion JPY | -62.4% |
2022 Q2 | 10.21 Billion JPY | 92.56% |
2022 Q1 | 5.3 Billion JPY | -15.86% |
2022 FY | 26.45 Billion JPY | -5.52% |
2022 Q4 | 6.24 Billion JPY | 33.41% |
2022 Q3 | 4.68 Billion JPY | -54.19% |
2021 Q1 | 6.6 Billion JPY | -3.96% |
2021 Q2 | 10.69 Billion JPY | 62.04% |
2021 Q4 | 6.3 Billion JPY | 43.6% |
2021 FY | 27.99 Billion JPY | 22.79% |
2021 Q3 | 4.39 Billion JPY | -58.95% |
2020 FY | 22.8 Billion JPY | 30.87% |
2020 Q2 | 6.41 Billion JPY | 17.94% |
2020 Q4 | 6.87 Billion JPY | 68.89% |
2020 Q1 | 5.44 Billion JPY | 26.18% |
2020 Q3 | 4.07 Billion JPY | -36.57% |
2019 Q4 | 4.31 Billion JPY | 34.16% |
2019 FY | 17.42 Billion JPY | 1.5% |
2019 Q3 | 3.21 Billion JPY | -43.87% |
2019 Q2 | 5.72 Billion JPY | 37.28% |
2019 Q1 | 4.17 Billion JPY | 2.38% |
2018 Q2 | 5.35 Billion JPY | 23.72% |
2018 FY | 17.16 Billion JPY | 18.79% |
2018 Q4 | 4.07 Billion JPY | 19.33% |
2018 Q1 | 4.32 Billion JPY | 4.39% |
2018 Q3 | 3.41 Billion JPY | -36.21% |
2017 Q2 | 4.6 Billion JPY | 64.31% |
2017 FY | 14.45 Billion JPY | 51.67% |
2017 Q4 | 4.14 Billion JPY | 43.24% |
2017 Q3 | 2.89 Billion JPY | -37.23% |
2017 Q1 | 2.8 Billion JPY | -6.06% |
2016 Q1 | 1.66 Billion JPY | 0.0% |
2016 FY | 9.52 Billion JPY | 27.81% |
2016 Q4 | 2.98 Billion JPY | 40.32% |
2016 Q3 | 2.12 Billion JPY | -22.59% |
2016 Q2 | 2.74 Billion JPY | 65.2% |
2015 FY | 7.45 Billion JPY | 0.0% |
2015 Q2 | 2.19 Billion JPY | 32.13% |
2015 Q3 | 1.68 Billion JPY | -23.13% |
2015 Q1 | 1.66 Billion JPY | -22.77% |
2014 Q4 | 2.15 Billion JPY | 17.92% |
2014 Q3 | 1.82 Billion JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alternative Energy Partners, Inc. | -3703.18 USD | 714278098.909% |
Allstar Health Brands, Inc. | -499.34 Thousand USD | 5297260.469% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | -38131.439% |
Café Serendipity Holdings, Inc. | -750.15 Thousand USD | 3526161.878% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | -49.02 Thousand USD | 53957506.879% |
HealthWarehouse.com, Inc. | -1.77 Million USD | 1491490.295% |
LIGAND PHARMACEUTICAL INC | 52.15 Million USD | -50617.107% |
MedGen, Inc. | -15.54 USD | 170212355312.355% |
Omni Health, Inc. | 1.26 Million USD | -2089832.437% |
Oxford Investments Holdings Inc. | -299.1 Thousand USD | 8843541.891% |
Pineapple, Inc. | -1.47 Million USD | 1790189.034% |
ScripsAmerica, Inc. | -4.73 Million USD | 559194.12% |